Crystal Market Research (CMR) render to you profound details in respect to leading participants, regions, application and type of the Autoimmune Disease Diagnostics Market which is estimated to encounter substantial growth over the forecast period 2018-2022.
Autoimmune Disease Diagnostics Market by Type – Global Industry Analysis and Forecast to 2022: Industry Trend Analysis
In 2012, the global autoimmune disease diagnostics market was worth around USD 11.62 billion and is predicted to reach around USD 15.11 billion by 2022, with a compound annual growth rate (CAGR) of 2.39% during the projected period. Increasing occurrence of autoimmune diseases like type 1 diabetes in infants combined with the requirement for speedy diagnostics are the major factors driving the growth of the global market. Diagnostics and research institutes around the world are attempting initiatives in defiance with governmental organizations due to growing occurrence of autoimmune diseases and subsequent increase in overall healthcare expenditure. As per the data released by the National Institutes of Health (NIH), these diseases have been graded as among the leading ten disorders directing to escalating rate of mortality among females. Technological innovations and rising rates of lab automation are expected to boost the growth of the global market. Practitioners are implementing highly developed technology with the aim of conducting various tests at the same time with quicker and more specific outcome. Reduced turnaround linked with the application of traditional illness diagnostic techniques as well as the existence of the lesser amount of standardized tests for more than 80 types of diseases are few of the defects advocating laboratories to shift in the direction of automation. Furthermore, the existence of encouraging governmental initiatives is expected to boost industry dynamics positively. Organizations like the Cooperative Study Group for Autoimmune Disease Prevention, North American Rheumatoid Arthritis Consortium, and Autoimmunity Centers of Excellence are actively involved in giving educative knowledge to healthcare professionals and patients about proper treatment as well as diagnosis. Rising awareness among patients regarding these disorders is anticipated to boost the growth of the global market. In 2013, a study was undertaken by the American Autoimmune Related Diseases Association, Inc. (AARDA) which suggests that the capability of an Americans to identify an autoimmune disease has improved by 10%. This rise can be attributed to widespread public awareness campaigns conducted by the AARDA in March 2014, like the National Awareness Campaign and Autoimmune Awareness Month.
Competitive Outlook and Trend Analysis
The market is amalgamated in nature, hence is noted by the existence of wide mergers and acquisitions. Some major participants of the global autoimmune disease diagnostics market are; Siemens Healthineers, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Abbott Laboratories, Quest Diagnostics, SQI Diagnostics, AESKU.Diagnostics GmbH & Co. KG, EUROIMMUN AG, INOVA Diagnostics, Inc., bioMerieux SA, Crescendo Bioscience, Inc., Hemagen Diagnostics, Inc., and Bio-Rad Laboratories, Inc. Novel products development for rapid and efficient diagnosis is major strategy attempted by most of the key industry participants. For example, during 2016, Inova Diagnostics declared the sanction of its Scl-70 assays, Jo-1 range of assays, and QUANTA Flash dsDNA for the diagnosis of systemic sclerosis, polymyositis & dermatomyositis, and systemic lupus erythematosus respectively.
Inquire for sample premium copy at: https://www.crystalmarketresearch.com/report/autoimmune-disease-diagnostics-market
Type Outlook and Trend Analysis
On account of type, autoimmune diseases are categorized into systemic and localized diseases. In 2015, localized illness diagnostics ruled the global market concerning revenue. The existence of huge process volumes and higher awareness level among patients as compared to systemic are few of the factors reporting for its large market share. Conversely, systemic illness diagnostics are projected to experience top growth during the projected period owing to the adoption of encouraging government initiatives, particularly the AMP RA/SLE program for people having systemic lupus erythematosus and rheumatoid arthritis. This program is expected to render a development platform for innovative treatment and invention of publicly approachable disease-specific and precompetitive database for more research application.
Regional Outlook and Trend Analysis
In 2015, North America regional market held the leading market share of around 40.0%, mostly owing to the initiation of the existence of positive regulations & initiatives attempted by the AARDA, elevated disease occurrence in this region and Affordable Care Act. As per the AARDA, almost 50 million people in America have some form of autoimmune disorder. An elevated occurrence of these diseases together with medical spending has actuated the launching of supportive initiatives by the governmental authorities and other market-friendly organizations. These encouraging initiatives intend to reduce medical expenditure by diagnosing the illness at a much earlier stage and escalating awareness levels of patients. Asia Pacific regional market is anticipated to experience lucrative expansion owing to continuously amending medical infrastructure, rising awareness levels among patients, and the existence of high unfulfilled patient demands. It is anticipated to witness a rise in revenue share over the forecast years. Its industry share is expected to expand from 21.0% to 22.0% over the period of 2015 to 2025.
Inquire about This Report at: https://www.crystalmarketresearch.com/send-an-enquiry/HC10282
Major Table of Contents:
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
22.214.171.124. Increasing Patient Awareness
126.96.36.199. Favorable Government Initiatives
188.8.131.52. Dearth of Skilled Professionals
4. Autoimmune Disease Diagnostics Market, By Type
4.2. Autoimmune Disease Diagnostics Market Assessment and Forecast, By Type, 2012-2022
4.3. Systemic Autoimmune Disease Diagnostics
4.3.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.3. Ankylosing Pondylitis
184.108.40.206. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.4. Rheumatoid Arthritis
220.127.116.11. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.5. Systemic Lupus Erythematosus (SLE)
18.104.22.168. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.6. Other Systemic Autoimmune Disease Diagnostics
22.214.171.124. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the rapid microbiology testing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Request Attractive Discount on the report at: https://www.crystalmarketresearch.com/check-discount/HC10282
About Crystal Market Research:
Crystal Market Research (CMR) is a main industry insight arrangement that gives all statistical surveying reports from top distributers, a U.S. based market research and business Intelligence Company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.